Carlo Bifulco, MD
Anatomic Pathology · New Haven, CTNPI 1528057155
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (30.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Illumina, Inc. at 42.3% of the total. Reporting peaked in 2022 at $10,348 and has fallen 85.5% since, to $1,498 in 2025.
Across 53 payments — averaging $361.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Illumina, Inc.$8K
- Sanofi$5K
- Merck$3K
- Agilent Technologies, Inc.$1K
- AstraZeneca$643
- Caris MPI, Inc.$304
- plus $710 from 6 others
What the payments were for
- Consulting fees$5,74630%
- Speaking & faculty fees$4,91926%
- Travel & lodging$3,63019%
- Food & beverage$3,08516%
- Gifts$1,7449%
- Entertainment$130%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Illumina, Inc. | 12 | $8,090 |
| Sanofi | 5 | $5,396 |
| Merck | 14 | $2,850 |
| Agilent Technologies, Inc. | 4 | $1,145 |
| AstraZeneca | 6 | $643 |
| Caris MPI, Inc. | 2 | $304 |
| Foundation Medicine, Inc. | 5 | $297 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| Pfizer | 1 | $114 |
| Tempus AI, Inc | 1 | $63 |
| AbbVie | 1 | $60 |
| E.r. Squibb & Sons, L.L.C. | 1 | $50 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Oncology Testing$4,419
- NovaSeq 6000Dx Sequencer Instrument$3,580
- KEYTRUDA$518
- MI CANCER SEEK$304
- LIBTAYO$125
- TAGRISSO$104
How this compares
$19,137 in reported general payments places this provider in the 80th percentile of 28 anatomic pathology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anatomic pathology in New Haven
- Sihem KhelifaNew Haven$169K
- David RimmNew Haven$126K
- Demetrios BraddockNew Haven$36K
- Nataia BuzaNew Haven$29K
- Dhanpat JainNew Haven$22K
- Pei HuiNew Haven$13K
- Laura ManuelidisNew Haven$4K
- John SinardNew Haven$2K
- Jennifer Moreira-DinzeyNew Haven$252
- Fattaneh TavassoliNew Haven$180
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.